Skip to content
zameds

Finerenone (Firialta, Cynfonera, Finetive)

Finerenone

Bayer (Pty) Ltd û Isando

Registration

Applicant
Bayer (Pty) Ltd û Isando
Registrations
6

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Firialta 10 MG

EACH TABLET CONTAINS FINERENONE 10,0 mg

10 mg57024257/18.10/0242RegisteredNot determinedNone
Firialta 20 MG

EACH TABLET CONTAINS FINERENONE 20,0 mg

20 mg57024357/18.10/0243RegisteredNot determinedNone
Cynfonera 10 MG

EACH TABLET CONTAINS FINERENONE 10,0 mg

10 mg570244.24257/18.10/02440242RegisteredNot determinedNone
Cynfonera 20 MG

EACH TABLET CONTAINS FINERENONE 20,0 mg

20 mg570245.24357/18.10/0245.243RegisteredNot determinedNone
Finetive 10 MG

EACH TABLET CONTAINS FINERENONE 10,0 mg

10 mg570246.24257/18.10/0246.242RegisteredNot determinedNone
Finetive 20 MG

EACH TABLET CONTAINS FINERENONE 20,0 mg

20 mg570247.24357/18.10/0427.243RegisteredNot determinedNone

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

C21H22N4O3378.40 g/mol

(4S)-4-(4-Cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide

Drag to rotate. Structure from PubChem CID 60150535.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles